Genertec Universal Medical (2666) Announces Completion of RMB1 Billion T4 Corporate Bond Issuance by Wholly-Owned Subsidiary China Universal Leasing

Bulletin Express12-04 16:43

Genertec Universal Medical Group Company Limited (Stock Code: 2666) announced the completion of the public issuance of the fourth tranche of corporate bonds (T4 Corporate Bonds) by its wholly-owned subsidiary China Universal Leasing Co., Ltd. on December 4, 2025. The total principal amount stands at RMB1 billion.

The T4 Corporate Bonds carry a basic term of five years starting from December 4, 2025, with a fixed interest rate of 2.25%. At the end of the third and fourth year, the issuer retains a repurchase option and may adjust the coupon rate, while bondholders hold a sell-back option. The issue price is RMB100 per bond, equivalent to 100% of the principal value.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment